Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - TOTAL CURRENT LIABILITIES
Total Current Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
968 M
LAST VALUE
-9.87%
2 YEAR CAGR
31.85%
5 YEAR CAGR
20.48%
10 YEAR CAGR